Design, synthesis and study of inhibitors of tryptophan 2,3-dioxygenase (TDO), a promising target for cancer therapy

Laurence Moineaux, Caroline Charlier, Eduard Dolusic, Pierre Larrieu, Luc Pilotte, Didier Colau, Vincent Stroobant, Moreno Galleni, Bernard Masereel, Benoît Van den Eynde, Johan Wouters (Supervisor), Raphaël Frédérick

Research output: Contribution to conferencePoster

Abstract

Immunotherapy is a promising novel strategy for cancer therapy. It consists of the therapeutic vaccination of cancer patients to stimulate their (natural) immune system against cancer cells. This approach, however, showed limited efficacy in vivo. Cancer cells are actually able to develop enzymatic mechanisms allowing tumours to resist or escape the immune rejection. Among the enzymes involved, the indoleamine 2,3-dioxygenases IDO and TDO represents potential actors. These enzymes catalyse the rapid degradation of tryptophan (Trp) through the kynurenine (KYN) pathway to form quinolinic acid (QA). This results in a local Trp depletion that severely affects the proliferation of T lymphocytes and is thereby profoundly immunosuppressive. This project was funded in part by Télévie (FNRS grant 7.4.543.07) and led in collaboration with the team of Pr Benoit Van Den Eynde (LICR, UCL) and Pr Moreno Galleni (CIP, ULG) aims at developing novel TDO inhibitors using a rational approach. These inhibitors will allow a better understanding of the role of TDO in the phenomenon of immunosuppression, especially in cancerous tumors. A series of vinyl-1H-indoles has been synthesized and their inhibitory potential has been evaluated on TDO of Ralstonia metallidurans (rmTDO) overexpressed in E.coli and purified by affinity chromatography. Crystallographic structure of some analogues was obtained and used as starting point for a docking study of these inhibitors in a model of humanized rmTDO. These data allowbetter understanding of how this family of inhibitors interact with TDO. This process is presented on this poster.
Original languageEnglish
PagesAbstracts, école doctorale SFMBBM, Liège, Belgium, 10 December 2010
Number of pages1
Publication statusPublished - 2010
Eventécole doctorale Structure et Fonction des Macromolécules Biologiques, Bioinformatique et Modélisation (SFMBBM) - Liège, Belgium
Duration: 10 Oct 2010 → …

Meeting

Meetingécole doctorale Structure et Fonction des Macromolécules Biologiques, Bioinformatique et Modélisation (SFMBBM)
CountryBelgium
CityLiège
Period10/10/10 → …

Keywords

  • immunosuppression
  • therapeutic vaccination
  • cancer
  • Ralstonia metallidurans
  • kynurenine
  • tryptophan 2 3-dioxygenase

Fingerprint Dive into the research topics of 'Design, synthesis and study of inhibitors of tryptophan 2,3-dioxygenase (TDO), a promising target for cancer therapy'. Together they form a unique fingerprint.

  • Projects

    Equipment

  • Activities

    • 3 Participation in conference

    Heterocycles in Bio-organic Chemistry

    Eduard Dolusic (Poster)

    27 May 2013

    Activity: Participating in or organising an event typesParticipation in conference

    BOSS XIII - 13th Belgian Organic Synthesis Symposium Louvain, 15 - 20 juillet 2012

    Eduard Dolusic (Poster)

    15 Jul 2012

    Activity: Participating in or organising an event typesParticipation in conference

    EFMC-ISMC 2010 XXIst INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY

    Eduard Dolusic (Poster)

    5 Sep 20109 Sep 2010

    Activity: Participating in or organising an event typesParticipation in conference

    Cite this

    Moineaux, L., Charlier, C., Dolusic, E., Larrieu, P., Pilotte, L., Colau, D., Stroobant, V., Galleni, M., Masereel, B., Van den Eynde, B., Wouters, J., & Frédérick, R. (2010). Design, synthesis and study of inhibitors of tryptophan 2,3-dioxygenase (TDO), a promising target for cancer therapy. Abstracts, école doctorale SFMBBM, Liège, Belgium, 10 December 2010. Poster session presented at école doctorale Structure et Fonction des Macromolécules Biologiques, Bioinformatique et Modélisation (SFMBBM), Liège, Belgium.